EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 2023
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RELEVANT RULES OF PROCEDURES
POLL RESULTS OFTHE 2023 FIRST EXTRAORDINARY GENERAL MEETING
2022 Environmental, Social and Governance & Corporate Social Responsibility Report
2022 ANNUAL REPORT
Notification Letter and Request Form to Non-registered Shareholders
VOLUNTARY ANNOUNCEMENT NATIONAL MEDICAL PRODUCTS ADMINISTRATION’S APPROVAL OF CLINICAL TRIAL APPLICATION FOR BIVALENT COVID-19 MRNA VACCINE
NOTICE OF BOARD MEETING
Monthly Return of Equity Issuer on Movements in Securities
2023 FIRST EXTRAORDINARY GENERAL MEETING
1
17
18
19
20
21
52
津公网安备12011602300399
